Please use this identifier to cite or link to this item:
Title: Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells
Authors: Liu, H. 
Lu, K.
Macary, P.A.
Wong, K.L.
Heng, A.
Cao, T. 
Kemeny, D.M.
Keywords: Allogeneic
Mesenchymal stromal cells
Stem cell transplantation
Issue Date: 2012
Citation: Liu, H., Lu, K., Macary, P.A., Wong, K.L., Heng, A., Cao, T., Kemeny, D.M. (2012). Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells. Journal of Cell Science 125 (1) : 200-208. ScholarBank@NUS Repository.
Abstract: Mesenchymal stromal cells (MSCs) possess both immuno-privileged and immuno-inhibitory properties that contribute to their therapeutic effects. Ex vivo expansion is required to obtain sufficient cells for therapy, but might also alter their immunological properties. To date there has been no systematic study of MSC immunobiology during extended culture. Here, we demonstrate that both immuno-privilege and immunosuppressive properties of MSCs change with increasing passage. We demonstrate that although MSCs exhibit powerful immunosuppressive effects through secretion of transforming growth factor-β (TGF-β) and induction of interleukin-10, these effects are diminished by a concomitant increase in MSC immunogenicity. Interferon-γ treatment for 3 days induced extendedly cultured MSCs to express significantly higher levels of major histocompatibility complex class I. In vivo, this results in cells that induce significant delayed-type hypersensitivity reactions in allogeneic recipients. Importantly, these effects are alleviated by isolation of the transplanted MSCs using a semi-permeable barrier. Under these conditions, even MSCs cultured through as many as 14 passages still exhibit immuno-inhibitory effects in vivo. Furthermore, the levels of anti-inflammatory molecule TGF-β secreted by MSCs were maintained in the extended culture. These data shed light on the variable results of allogeneic MSCs in transplantation and suggest alternative strategies for prolonging the effect of allogeneic MSCs in cell-based therapy. © 2012.
Source Title: Journal of Cell Science
ISSN: 00219533
DOI: 10.1242/jcs.093070
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Mar 18, 2019


checked on Mar 18, 2019

Page view(s)

checked on Jan 12, 2019

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.